Assessing prescriptions for statins in ambulatory diabetic patients in the United States: A national, cross-sectional study

Clinical Therapeutics

Volumn 30, Issue 11, 2008, Pages 2159-2166

  Segars, Larry W ^a   Lea, Amanda R ^b  

^a KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

^b Des Peres Hospital   (United States)

Author keywords

diabetes mellitus; National Ambulatory Medical Care Survey (NAMCS); National Hospital Ambulatory Medical Care Survey (NHAMCS); outpatient; statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AMBULATORY CARE; ARTICLE; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; PRESCRIPTION; UNITED STATES;

AMBULATORY CARE; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; DRUG PRESCRIPTIONS; DRUGS, GENERIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; ODDS RATIO; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; SEX FACTORS; UNITED STATES;

EID: 57649216923     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.11.004     Document Type: Article

References (18)

1. American Diabetes Association. Complications of diabetes in the United States.
2. (April 7, 2007). http://www.diabetes.org/diabetes-statistics/complications.jsp Accessed
3. Leiter L.A. Should you put all diabetic patients on statins?. J Fam Pract 56 (2007) 294-300
4. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 25 (2002) 213-229
5. American Diabetes Association. Standards of medical care for patients with diabetes mellitus [published correction appears in Diabetes Care. 2003;26:972]. Diabetes Care 26 Suppl 1 (2003) S33-S50
6. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 27 Suppl 1 (2004) S15-S35
7. American Diabetes Association. Standards of medical care in diabetes [published correction appears in Diabetes Care. 2005;28:990]. Diabetes Care 28 Suppl 1 (2005) S4-S36
8. American Diabetes Association. Standards of medical care in diabetes-2006 [published correction appears in Diabetes Care. 2006;29:1192]. Diabetes Care 29 Suppl 1 (2006) S4-S42
9. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl 1 (2007) S4-S41
10. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
11. Brown L.C., Johnson J.A., Majumdar S.R., et al. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 171 (2004) 1189-1192
12. Avogaro A., Guida P., Giorda C., et al., for the Progetto DIARIO (DIAbetic Register in Italian Offices). The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy. Nutr Metab Cardiovasc Dis 17 (2007) 32-40
13. Damci T., Kultursay H., Oguz A., et al., for the Vascular Risk Study Group. Sub-optimal drug treatment of diabetes and cardiovascular risk in diabetic patients in Turkey. A countrywide survey. Diabetes Metab 30 (2004) 327-333
14. Centers for Disease Control and Prevention, National Center for Health Statistics. Ambulatory health care data.
15. (May 5, 2007). http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm Accessed
16. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). 5th ed (1997), Medicode Publications, Salt Lake City, Utah
17. Collins R., Armitage J., Parish S., et al., for the Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterollowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
18. Colhoun H.M., Betteridge D.J., Durrington P.N., et al., for the CARDS Investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 364 (2004) 685-696